Reply: Heterozygous PINK1 p.G411S in rapid eye movement sleep behaviour disorder.

Andreas Puschmann, Fabienne C. Fiesel, Thomas R. Caulfield, Roman Hudec, Maya Ando, Dominika Truban, Xu Hou, Kotaro Ogaki, Michael G. Heckman, Elle D. James, Maria Swanberg, Itzia Jimenez-Ferrer, Oskar Hansson, Grzegorz Opala, Joanna Siuda, Magdalena Boczarska-Jedynak, Andrzej Friedman, Dariusz Koziorowski, Monika Rudzińska-Bar, Jan O. Aasly, Timothy Lynch, George D. Mellick, Megha Mohan, Peter A. Silburn, Yanosh Sanotsky, Carles Vilariño-Güell, Matthew J. Farrer, Li Chen, Valina L. Dawson, Ted M. Dawson, Zbigniew K. Wszolek, Owen A. Ross and Wolfdieter Springer

[1]  J. Molinuevo,et al.  Neurodegenerative Disorder Risk in Idiopathic REM Sleep Behavior Disorder: Study in 174 Patients , 2014, PloS one.

[2]  R. Postuma,et al.  Heterozygous PINK1 p.G411S in rapid eye movement sleep behaviour disorder. , 2017, Brain : a journal of neurology.

[3]  Anna Potulska-Chromik,et al.  Novel A18T and pA29S substitutions in α-synuclein may be associated with sporadic Parkinson's disease. , 2013, Parkinsonism & related disorders.

[4]  Carlos H Schenck,et al.  Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. , 2013, Sleep medicine.

[5]  P. Svenningsson,et al.  Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden , 2016, Neurobiology of Aging.

[6]  T. Caulfield,et al.  PINK1, Parkin, and Mitochondrial Quality Control: What can we Learn about Parkinson’s Disease Pathobiology? , 2016, Journal of Parkinson's disease.

[7]  M. Farrer,et al.  Heterozygous PINK1 p.G411S increases risk of Parkinson’s disease via a dominant-negative mechanism , 2016, Brain : a journal of neurology.

[8]  N. Hattori,et al.  Absence of Lewy pathology associated with PINK1 homozygous mutation , 2016, Neurology.

[9]  K. Marder,et al.  Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium , 2015, Neurology.

[10]  Daniel F. A. R. Dourado,et al.  Structural and Functional Impact of Parkinson Disease‐Associated Mutations in the E3 Ubiquitin Ligase Parkin , 2015, Human mutation.